It can be extrapolated that POCU1b may act as an anti-obesity agent by inhibiting pancreatic lipase and mediating cAMP-dependent PDE inhibition, leading to reduced perilipin and ADRP levels. The gene discussed is PLIN1; the disease is Obesity.